NCT00070590View on ClinicalTrials.gov

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Pulmonary FibrosisScleroderma, Systemic
Interventions
DRUG

Bosentan

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY